Long-term risk of death after tuberculosis diagnosis and treatment
Summary
Tuberculosis (TB) remains a major societal burden, yet data on long-term mortality following TB diagnosis and treatment are limited. We conducted a nationwide Brazilian cohort study using linked data (2004-2018) to quantify long-term mortality (up to 14 years) following TB. We matched: (i) individuals diagnosed with TB or (ii) individuals who had completed TB treatment to TB-free individuals. We used competing risk methods to analyze natural causes (that is, defined as deaths excluding TB,
Content
# Long-term risk of death after tuberculosis diagnosis and treatment
*Published: 2026 May*
Tuberculosis (TB) remains a major societal burden, yet data on long-term
mortality following TB diagnosis and treatment are limited. We conducted a
nationwide Brazilian cohort study using linked data (2004-2018) to quantify
long-term mortality (up to 14 years) following TB. We matched: (i) individuals
diagnosed with TB or (ii) individuals who had completed TB treatment to TB-free
individuals. We used competing risk methods to analyze natural causes (that is,
defined as deaths excluding TB, HIV and external causes) and cause-specific
mortality. In the diagnosed cohort (185,921 pairs), the risk of 14-year natural
cause mortality was significantly higher (risk ratio (RR) = 2.16, 95% confidence
interval = 1.96-2.37); RRs were significantly elevated for deaths due to cancer,
cardiovascular, endocrine, respiratory and external causes. The treated cohort
(111,871 pairs) presented elevated natural cause mortality risk
(RR = 1.77,1.55-2.03), with similarly increased RRs across specific causes. We
showed that TB survivors, even after treatment, faced a significantly elevated,
prolonged risk of death from various causes up to 14 years later. This finding
highlights the need for long-term monitoring to reduce the burden of TB.
DOI: 10.1038/s41591-026-04294-w